227 related articles for article (PubMed ID: 18642290)
21. Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence.
Zhi X; Lamperska K; Golusinski P; Schork NJ; Luczewski L; Kolenda T; Golusinski W; Masternak MM
Oncotarget; 2015 Jan; 6(1):547-55. PubMed ID: 25575813
[TBL] [Abstract][Full Text] [Related]
22. P53 allelic loss and outcome in patients with squamous cell carcinoma of the head and neck.
Rodrigo JP; Coto E; González MV; Maldonado M; Suárez C
Eur Arch Otorhinolaryngol; 2001 Jul; 258(5):255-8. PubMed ID: 11548906
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease.
Lazar AD; Winter MR; Nogueira CP; Larson PS; Finnemore EM; Dolan RW; Fuleihan N; Chakravarti A; Zietman A; Rosenberg CL
Clin Cancer Res; 1998 Nov; 4(11):2787-93. PubMed ID: 9829743
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
[TBL] [Abstract][Full Text] [Related]
25. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
[TBL] [Abstract][Full Text] [Related]
26. [Loss of heterozygosity of 3p21 and 9p21 in head and neck squamous cell carcinomas and its prognostic implication].
Matsuura K; Shiga K; Yokoyama J; Tateda M; Nakano H; Saijo S; Takasaka T
Nihon Jibiinkoka Gakkai Kaiho; 1999 May; 102(5):613-21. PubMed ID: 10388315
[TBL] [Abstract][Full Text] [Related]
27. Genomic instabilities in squamous cell carcinoma of head and neck from the Indian population.
Chakrabarti S; Sengupta S; Sengupta A; Basak SN; Roy A; Panda C; Roychoudhury S
Mol Carcinog; 2006 Apr; 45(4):270-7. PubMed ID: 16402388
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis.
Gasparotto D; Vukosavljevic T; Piccinin S; Barzan L; Sulfaro S; Armellin M; Boiocchi M; Maestro R
Int J Cancer; 1999 Aug; 84(4):432-6. PubMed ID: 10404099
[TBL] [Abstract][Full Text] [Related]
30. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer.
Gleich LL; Li YQ; Biddinger PW; Gartside PS; Stambrook PJ; Pavelic ZP; Gluckman JL
Laryngoscope; 1996 Nov; 106(11):1378-81. PubMed ID: 8914904
[TBL] [Abstract][Full Text] [Related]
31. Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck.
Pearlstein RP; Benninger MS; Carey TE; Zarbo RJ; Torres FX; Rybicki BA; Dyke DL
Genes Chromosomes Cancer; 1998 Apr; 21(4):333-9. PubMed ID: 9559345
[TBL] [Abstract][Full Text] [Related]
32. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
33. Microsatellite instability and loss of heterozygosity in squamous cell carcinoma of the head and neck.
Koy S; Plaschke J; Luksch H; Friedrich K; Kuhlisch E; Eckelt U; Martinez R
Head Neck; 2008 Aug; 30(8):1105-13. PubMed ID: 18615731
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 22q a frequent site of allele loss in head and neck carcinoma.
Poli-Frederico RC; Bergamo NA; Reis PP; Kowalski LP; Zielenska M; Squire JA; Rogatto SR
Head Neck; 2000 Sep; 22(6):585-90. PubMed ID: 10941160
[TBL] [Abstract][Full Text] [Related]
35. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression.
van der Riet P; Nawroz H; Hruban RH; Corio R; Tokino K; Koch W; Sidransky D
Cancer Res; 1994 Mar; 54(5):1156-8. PubMed ID: 8118798
[TBL] [Abstract][Full Text] [Related]
36. Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.
Beder LB; Gunduz M; Ouchida M; Gunduz E; Sakai A; Fukushima K; Nagatsuka H; Ito S; Honjo N; Nishizaki K; Shimizu K
J Cancer Res Clin Oncol; 2006 Jan; 132(1):19-27. PubMed ID: 16170569
[TBL] [Abstract][Full Text] [Related]
37. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma.
Takebayashi S; Ogawa T; Jung KY; Muallem A; Mineta H; Fisher SG; Grenman R; Carey TE
Cancer Res; 2000 Jul; 60(13):3397-403. PubMed ID: 10910046
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
40. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
